A study has found that dysphagia is associated with poor stroke prognosis, including increased risk of breathing difficulties, malnutrition, and even death, possibly due to oral food intake affecting the oral and gut microbiota of patients undergoing enteral nutrition rehabilitation (Katagiri et al., 2019)
The Tirzepatide Injection protocol is $289/mo month-to-month, or from $249/mo on the 6-month plan, all-inclusive of the provider visit, prescription, medication, and shipping, with no membership fee
Regulatory status: AOD-9604 is not an approved human medicinal product in the EU or the USA (FDA NDI rejection 2014)
For optimal absorption, many people find success taking them in the morning on an empty stomach or at night before bed
Most users notice improved radiance and energy within 2-4 weeks